Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-24 @ 9:42 PM
NCT ID:
NCT03285932
Eligibility Criteria:
Inclusion Criteria:
* histologically confirmed solid cancer
* MRI confirmed cerebral metastases
* Neurosurgical resection of one cerebral metastasis
* age ≥ 18 years of age
* Karnofsky Performance Score \>60
* for women with childbearing potential, (and men) adequate contraception.
* ability to understand character and individual consequences of the clinical trial
* written informed consent (must be available before enrolment in the trial)
Exclusion Criteria:
* refusal of the patients to take part in the study
* previous radiotherapy to the brain
* \> 10 unresected brain metastases in postoperative MRI
* Patients who have not yet recovered from acute toxicities of prior therapies
* known carcinoma \< 2 years ago (excluding carcinoma in situ of the cervix, basal cell carcinoma, squamous cell carcinoma of the skin) requiring immediate treatment interfering with study therapy
* pregnant or lactating women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03285932
Study Brief:
Protocol Section:
NCT03285932